KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Gross Profit (2016 - 2025)

Historic Gross Profit for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $683.4 million.

  • Idexx Laboratories' Gross Profit rose 1464.94% to $683.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 billion, marking a year-over-year increase of 1018.2%. This contributed to the annual value of $2.4 billion for FY2024, which is 862.83% up from last year.
  • As of Q3 2025, Idexx Laboratories' Gross Profit stood at $683.4 million, which was up 1464.94% from $694.7 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Gross Profit ranged from a high of $694.7 million in Q2 2025 and a low of $456.4 million during Q4 2021
  • For the 5-year period, Idexx Laboratories' Gross Profit averaged around $550.7 million, with its median value being $543.0 million (2023).
  • In the last 5 years, Idexx Laboratories' Gross Profit skyrocketed by 3092.19% in 2021 and then skyrocketed by 505.29% in 2022.
  • Over the past 5 years, Idexx Laboratories' Gross Profit (Quarter) stood at $456.4 million in 2021, then grew by 6.25% to $484.9 million in 2022, then increased by 8.5% to $526.2 million in 2023, then rose by 8.46% to $570.7 million in 2024, then increased by 19.75% to $683.4 million in 2025.
  • Its Gross Profit was $683.4 million in Q3 2025, compared to $694.7 million in Q2 2025 and $623.4 million in Q1 2025.